Are we living in an age of overmedicalisation? Overdiagnosis of conditions such as autism, ADHD and depression is a result of ...
A landmark clinical trial testing the effect of microdosing LSD on symptoms of attention-deficit hyperactive disorder (ADHD) ...
Solriamfetol, a new treatment for ADHD, showed a 45% reduction in symptoms in a Phase 3 trial. This treatment targets ...
In the intricate world of brain health, a curious link has emerged between Attention-Deficit/Hyperactivity Disorder (ADHD) ...
Nearly 4 in 5 people with ADHD have a co-occurring condition. We review some of the most common, their link to ADHD, and how ...
Every child with autism or ADHD is unique, so a one-size-fits-all approach doesn’t work. Experts stress the importance of ...
The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on ...
A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...
Discover the 6 key aspects of ADHD that help parents understand symptoms, diagnosis, and support options to ensure children ...
People who took twice-weekly low doses of LSD experienced no greater improvement in their ADHD symptoms than people taking ...
At least 50% of children and adults with ADHD report substantial sleep problems, including delayed sleep phase syndrome and insomnia, leading to disrupted or insufficient sleep. Adults with ADHD have ...
Adults with ADHD show changes such as higher iron accumulation in the brain — similar to early-stage dementia — which could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results